{"abdominal rigidity": 5.09, "acute myeloid leukaemia": 6.46, "acute respiratory distress syndrome": 2.83, "adenocarcinoma": 6.2, "agranulocytosis": 11.69, "alopecia": 6.63, "alopecia areata": 37.26, "alopecia totalis": 37.52, "anaemia": 3.29, "bacteraemia": 2.53, "bicytopenia": 21.24, "bone lesion": 6.4, "bone marrow failure": 2.66, "bone pain": 2.49, "breast cancer metastatic": 8.28, "breast cancer recurrent": 14.33, "capillary leak syndrome": 6.61, "cardiac dysfunction": 4.14, "cardiac failure": 2.23, "cardiomyopathy": 2.45, "cardiotoxicity": 16.66, "colitis": 3.23, "cytopenia": 5.67, "dacryostenosis acquired": 73.42, "decreased appetite": 2.44, "dermatitis acneiform": 2.63, "device related infection": 3.07, "diarrhoea": 3.09, "dilated cardiomyopathy": 2.34, "disease progression": 7.58, "ejection fraction decreased": 18.33, "enteritis": 6.7, "enterocolitis": 7.27, "febrile bone marrow aplasia": 13.27, "febrile neutropenia": 28.35, "flushing": 4.16, "foreign body sensation in eyes": 5.45, "gastrointestinal toxicity": 13.53, "granulocyte count decreased": 36.01, "granulocytopenia": 15.65, "haematotoxicity": 14.86, "hair colour changes": 39.78, "hair texture abnormal": 60.67, "hepatic function abnormal": 3.66, "hepatic lesion": 4.86, "hormone-refractory prostate cancer": 19.24, "hypoalbuminaemia": 2.88, "hypocalcaemia": 3.28, "hypomagnesaemia": 2.83, "hypophagia": 2.19, "infusion related reaction": 4.94, "injury": 2.43, "interstitial lung disease": 3.95, "invasive ductal breast carcinoma": 5.57, "lacrimal structure injury": 3172.44, "lacrimation increased": 8.27, "large intestine perforation": 5.02, "left ventricular dysfunction": 10.48, "leukopenia": 8.5, "liver injury": 2.08, "lung adenocarcinoma": 9.9, "lymphocyte count decreased": 2.57, "lymphopenia": 3.15, "madarosis": 93.99, "maligt neoplasm progression": 5.69, "metastases to bone": 15.48, "metastases to central nervous system": 9.81, "metastases to liver": 10.71, "metastases to lung": 14.3, "metastases to lymph nodes": 16.2, "metastases to pleura": 16.48, "metastases to skin": 14.78, "metastases to spine": 7.24, "metastases to the mediastinum": 37.98, "metastasis": 13.05, "mouth ulceration": 2.25, "mucosal inflammation": 14.68, "myelodysplastic syndrome": 4.85, "myelosuppression": 51.76, "nail discolouration": 6.79, "nail disorder": 20.04, "neoplasm progression": 2.74, "neoplasm recurrence": 5.76, "neuropathy peripheral": 5.1, "neurotoxicity": 3.21, "neutropenia": 9.89, "neutropenic colitis": 33.61, "neutropenic sepsis": 9.2, "neutrophil count decreased": 34.74, "neutrophil count increased": 2.65, "non-small cell lung cancer": 11.89, "oesophagitis": 2.27, "onycholysis": 37.71, "osteonecrosis of jaw": 2.83, "palmar-plantar erythrodysaesthesia syndrome": 8.14, "paronychia": 5.95, "peripheral sensory neuropathy": 4.52, "platelet count decreased": 2.14, "pleural effusion": 3.39, "pneumatosis intestinalis": 6.06, "pneumocystis jirovecii pneumonia": 2.23, "pneumonitis": 2.58, "polyneuropathy": 8.18, "portal venous gas": 68.8, "prostate cancer metastatic": 16.11, "prostatic specific antigen increased": 10.1, "pulmonary mass": 3.28, "second primary maligcy": 7.8, "septic shock": 4.97, "skin exfoliation": 2.17, "skin toxicity": 12.31, "stomatitis": 6.37, "subclavian vein thrombosis": 17.26, "systemic scleroderma": 19.48, "therapy partial responder": 7.73, "thrombocytopenia": 2.0, "toxic skin eruption": 2.33, "transaminases increased": 2.03, "tumour lysis syndrome": 3.11, "vascular device infection": 3.71, "white blood cell count decreased": 25.81}